IL75411A0 - Dihydropyridines and pharmaceutical compositions containing them - Google Patents

Dihydropyridines and pharmaceutical compositions containing them

Info

Publication number
IL75411A0
IL75411A0 IL75411A IL7541185A IL75411A0 IL 75411 A0 IL75411 A0 IL 75411A0 IL 75411 A IL75411 A IL 75411A IL 7541185 A IL7541185 A IL 7541185A IL 75411 A0 IL75411 A0 IL 75411A0
Authority
IL
Israel
Prior art keywords
dihydropyridines
pharmaceutical compositions
compositions containing
pharmaceutical
compositions
Prior art date
Application number
IL75411A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848414520A external-priority patent/GB8414520D0/en
Priority claimed from GB858508736A external-priority patent/GB8508736D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of IL75411A0 publication Critical patent/IL75411A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL75411A 1984-06-07 1985-06-05 Dihydropyridines and pharmaceutical compositions containing them IL75411A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848414520A GB8414520D0 (en) 1984-06-07 1984-06-07 Dihydropyridines
GB858508736A GB8508736D0 (en) 1985-04-03 1985-04-03 Dihydropyridines

Publications (1)

Publication Number Publication Date
IL75411A0 true IL75411A0 (en) 1985-10-31

Family

ID=26287832

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75411A IL75411A0 (en) 1984-06-07 1985-06-05 Dihydropyridines and pharmaceutical compositions containing them

Country Status (14)

Country Link
US (1) US4618609A (fr)
EP (1) EP0164247B1 (fr)
JP (1) JPH0641464B2 (fr)
AU (1) AU556496B2 (fr)
DE (1) DE3567460D1 (fr)
DK (1) DK170402B1 (fr)
ES (1) ES8700857A1 (fr)
FI (1) FI852222L (fr)
GR (1) GR851383B (fr)
HU (1) HUT41404A (fr)
IE (1) IE57816B1 (fr)
IL (1) IL75411A0 (fr)
PL (1) PL253821A1 (fr)
PT (1) PT80597B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
WO1987000836A1 (fr) * 1985-08-06 1987-02-12 Boehringer Biochemia Robin S.P.A. 1,4-dihydropyridines pharmaceutiquement actives a substitution 2-thiomethyle
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
US4761420A (en) * 1986-06-13 1988-08-02 Laboratoires Syntex S.A. Antihypertensive dihydropyridine derivatives
US4920134A (en) * 1987-08-07 1990-04-24 Takeda Chemical Industries, Ltd. 2-O-pyrimidinyl glycerol derivatives
US5424321A (en) * 1993-12-08 1995-06-13 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
US5691360A (en) * 1993-12-08 1997-11-25 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
WO2005077344A2 (fr) 2003-08-29 2005-08-25 The Brigham And Women's Hospital, Inc. Inhibiteurs de la necrose cellulaire
WO2010075290A1 (fr) * 2008-12-22 2010-07-01 President And Fellows Of Harvard College Inhibiteurs hétérocycliques insaturés de la nécroptose
AU2009329879A1 (en) 2008-12-23 2011-08-11 President And Fellows Of Harvard College Small molecule inhibitors of necroptosis
US9725452B2 (en) 2013-03-15 2017-08-08 Presidents And Fellows Of Harvard College Substituted indoles and pyrroles as RIP kinase inhibitors
EP3229807A4 (fr) 2014-12-11 2018-10-17 President and Fellows of Harvard College Inhibiteurs de nécrose cellulaire et procédés associés

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2951945A1 (de) * 1979-12-22 1981-07-02 Ibm Deutschland Gmbh, 7000 Stuttgart Schaltungsanordnung zur kapazitiven lesesignalverstaerkung in einem integrierten halbleiterspeicher mit einem intergrierten halbleiterspeicher mit speicherzellen in mtl-technik
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
US4572908A (en) * 1982-12-21 1986-02-25 Pfizer Inc. Dihydropyridines
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
HUT41404A (en) 1987-04-28
AU4334985A (en) 1985-12-12
ES8700857A1 (es) 1986-11-16
EP0164247A1 (fr) 1985-12-11
IE57816B1 (en) 1993-04-21
PT80597A (en) 1985-07-01
DK253785D0 (da) 1985-06-06
AU556496B2 (en) 1986-11-06
PL253821A1 (en) 1986-07-01
US4618609A (en) 1986-10-21
DK253785A (da) 1985-12-08
FI852222L (fi) 1985-12-08
DK170402B1 (da) 1995-08-21
IE851417L (en) 1985-12-07
EP0164247B1 (fr) 1989-01-11
JPH0641464B2 (ja) 1994-06-01
FI852222A0 (fi) 1985-06-03
DE3567460D1 (en) 1989-02-16
GR851383B (fr) 1985-11-25
ES543999A0 (es) 1986-11-16
PT80597B (en) 1987-04-23
JPS611685A (ja) 1986-01-07

Similar Documents

Publication Publication Date Title
IL74758A (en) Acyltripeptides and pharmaceutical compositions containing them
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
IL74726A (en) N-aryl-n-(4-piperidinyl)amides and pharmaceutical compositions containing them
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
IL75326A0 (en) Quinolone derivatives and pharmaceutical compositions containing them
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
NZ213821A (en) Piperidine derivatives and pharmaceutical compositions
IL74865A0 (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL79376A (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
IL75411A0 (en) Dihydropyridines and pharmaceutical compositions containing them
IL75242A0 (en) Pharmaceutical compositions containing dihydropyridines and their preparation
IL75427A0 (en) Dihydropyridines and pharmaceutical compositions containing them
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
IL80540A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them
IL78642A0 (en) Dihydropyridines and pharmaceutical compositions containing them
IL74071A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
IL75241A0 (en) Pharmaceutical compositions containing nifedipine and their preparation